Publication & Citation Trends
Publications
0 total
Novel Compound Beneficial as Adjunct to Antibody-Based Therapy for Stage IV NSCLC Patients
Cited by 0
Semantic Scholar
ALTER0302: Anlotinib Increased PFS as Third-Line Treatment for Refractory Advanced NSCLC
Cited by 0
Semantic Scholar
LUX-Lung 5: Afatinib Plus Paclitaxel Improves Outcomes for Metastatic NSCLC
Cited by 1
Semantic Scholar
TIME Trial: Efficacy of TG4010 Immunotherapy With First-Line Chemotherapy in NSCLC
Cited by 0
Semantic Scholar
Age-Stratified Subgroup Analysis of SQUIRE in Patients With Stage IV Squamous NSCLC
Cited by 0
Semantic Scholar
Identification of a Novel Inhibitor of the NF-κB Pathway
Cited by 7
Semantic Scholar
The Cyclic Adenosine Monophosphate-dependent Protein Kinase (PKA) Is Required for the Sustained Activation of Mitogen-activated Kinases and Gene Expression by Nerve Growth Factor* OA
Cited by 142
Semantic Scholar
Research Topics
Growth Hormone and Insulin-like Growth Factors
(4)
Protein Kinase Regulation and GTPase Signaling
(3)
Lung Cancer Treatments and Mutations
(3)
Lung Cancer Diagnosis and Treatment
(2)
RNA modifications and cancer
(2)
Affiliations
Howard Hughes Medical Institute
Oregon Health & Science University
Shanghai Chest Hospital
Vollum Institute
The Netherlands Cancer Institute